Berliner Boersenzeitung - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.312929
AFN 77.614184
ALL 96.718499
AMD 447.885668
ANG 2.102622
AOA 1076.910747
ARS 1684.665547
AUD 1.766005
AWG 2.113892
AZN 2.001718
BAM 1.956174
BBD 2.362352
BDT 143.337416
BGN 1.955536
BHD 0.442185
BIF 3466.733567
BMD 1.174385
BND 1.514777
BOB 8.10455
BRL 6.361717
BSD 1.172924
BTN 106.071288
BWP 15.540973
BYN 3.457761
BYR 23017.938669
BZD 2.358951
CAD 1.616264
CDF 2630.621898
CHF 0.934158
CLF 0.027326
CLP 1071.966169
CNY 8.284694
CNH 8.277961
COP 4465.574052
CRC 586.712221
CUC 1.174385
CUP 31.121193
CVE 110.286095
CZK 24.282287
DJF 208.869951
DKK 7.469169
DOP 74.564262
DZD 151.638713
EGP 55.574111
ERN 17.615769
ETB 183.267854
FJD 2.667962
FKP 0.878731
GBP 0.878516
GEL 3.168336
GGP 0.878731
GHS 13.464575
GIP 0.878731
GMD 85.730058
GNF 10200.86427
GTQ 8.983718
GYD 245.386935
HKD 9.140194
HNL 30.879906
HRK 7.535086
HTG 153.738097
HUF 384.664394
IDR 19569.651811
ILS 3.784801
IMP 0.878731
INR 106.336241
IQD 1536.493887
IRR 49468.014111
ISK 148.395229
JEP 0.878731
JMD 187.79592
JOD 0.832679
JPY 182.411354
KES 151.248422
KGS 102.699679
KHR 4695.858197
KMF 492.652086
KPW 1056.945796
KRW 1734.283949
KWD 0.360178
KYD 0.977487
KZT 611.717004
LAK 25427.863618
LBP 105034.290035
LKR 362.429322
LRD 207.019597
LSL 19.788685
LTL 3.467653
LVL 0.710373
LYD 6.371219
MAD 10.790664
MDL 19.827792
MGA 5195.993844
MKD 61.561513
MMK 2465.34558
MNT 4164.209668
MOP 9.405299
MRU 46.939978
MUR 53.927786
MVR 18.084284
MWK 2033.889024
MXN 21.14617
MYR 4.802094
MZN 75.055099
NAD 19.788685
NGN 1701.860126
NIO 43.167889
NOK 11.889088
NPR 169.714461
NZD 2.031128
OMR 0.449556
PAB 1.172924
PEN 3.948955
PGK 5.055924
PHP 69.371492
PKR 328.708572
PLN 4.222799
PYG 7878.506931
QAR 4.274718
RON 5.091076
RSD 117.401956
RUB 93.302751
RWF 1707.126524
SAR 4.406528
SBD 9.602651
SCR 17.572211
SDG 706.397517
SEK 10.878049
SGD 1.516277
SHP 0.881093
SLE 28.331997
SLL 24626.262717
SOS 669.127985
SRD 45.270159
STD 24307.390684
STN 24.504478
SVC 10.262963
SYP 12984.797151
SZL 19.781784
THB 37.027764
TJS 10.779062
TMT 4.12209
TND 3.428856
TOP 2.827637
TRY 50.144348
TTD 7.959522
TWD 36.749787
TZS 2901.991297
UAH 49.558779
UGX 4168.797371
USD 1.174385
UYU 46.028804
UZS 14130.642623
VES 314.07713
VND 30889.838816
VUV 142.250431
WST 3.259484
XAF 656.08249
XAG 0.018738
XAU 0.000271
XCD 3.173833
XCG 2.113904
XDR 0.815956
XOF 656.08249
XPF 119.331742
YER 280.089731
ZAR 19.811982
ZMK 10570.858023
ZMW 27.065177
ZWL 378.15137
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.0000

    81.17

    0%

  • BCC

    0.2500

    76.51

    +0.33%

  • NGG

    0.2400

    74.93

    +0.32%

  • CMSD

    -0.1500

    23.25

    -0.65%

  • GSK

    -0.0700

    48.81

    -0.14%

  • AZN

    -0.4600

    89.83

    -0.51%

  • RIO

    -1.0800

    75.66

    -1.43%

  • RELX

    0.1000

    40.38

    +0.25%

  • CMSC

    -0.1300

    23.3

    -0.56%

  • BCE

    0.3100

    23.71

    +1.31%

  • BTI

    -1.2700

    57.1

    -2.22%

  • JRI

    -0.0200

    13.7

    -0.15%

  • VOD

    0.0500

    12.59

    +0.4%

  • RYCEF

    -0.2500

    14.6

    -1.71%

  • BP

    -0.2700

    35.26

    -0.77%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

(S.G.Stein--BBZ)